An open label exploratory study to assess the feasibility of using 100mg of methotrexate as a standard dose treatment for women with unruptured tubal ectopic pregnancies

Project Details

StatusActive
Effective start/end date20/12/1919/06/21

Funding

  • Other: £78,853.00